0001209191-18-047055.txt : 20180816
0001209191-18-047055.hdr.sgml : 20180816
20180816162624
ACCESSION NUMBER: 0001209191-18-047055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180814
FILED AS OF DATE: 20180816
DATE AS OF CHANGE: 20180816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooper Ronald Harold Wilfred
CENTRAL INDEX KEY: 0001676880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 181023603
MAIL ADDRESS:
STREET 1: C/O GENOCEA BIOSCIENCES, INC.
STREET 2: 100 ACORN PARK DRIVE, 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-14
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001676880
Cooper Ronald Harold Wilfred
C/O ALBIREO PHARMA INC.
10 POST OFFICE SQUARE, SUITE 502 SOUTH
BOSTON
MA
02109
1
1
0
0
President and CEO
Common Stock
2018-08-14
4
P
0
588
31.63
A
6534
D
Common Stock
2018-08-14
4
P
0
200
32.50
A
6734
D
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2018.
This transaction was executed in multiple trades at prices ranging from $31.39
to $31.83. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Jason Duncan, Attorney-in-fact
2018-08-16